Morningstar Investor users sign in here.

Company Profile

  • Business description

    Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

  • Contact

    455 Mission Bay Boulevard South
    San Francisco CA 94158
    USA

    T: +1 415 482-5300

    E: Investors@nektar.com

    https://www.nektar.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    137

Stocks News & Analysis

stocks

Morningstar initiates on McMillan Shakespeare

The firm dominates its core markets. 
stocks

3 undervalued US value shares with moats

Value continues to underperforming but it may be a function of how we think about the investing style.  
stocks

Undervalued energy producer reports earnings

Guidance creditably maintained despite cyclones. 

Markets

Index
Last price
Change
% Change
All Ordinaries 7,902.00 84.60 1.08%
CAC 40 8,022.41 0.85 -0.01%
DAX 40 17,737.36 100.04 -0.56%
Dow JONES (US) 37,986.40 211.02 0.56%
FTSE 100 7,895.85 18.80 0.24%
HKSE 16,510.88 286.74 1.77%
NASDAQ 15,282.01 319.49 -2.05%
Nikkei 225 37,438.61 370.26 1.00%
NZX 50 Index 11,852.80 56.59 0.48%
S&P 500 4,967.23 43.89 -0.88%
S&P/ASX 200 7,649.20 81.90 1.08%
SSE Composite Index 3,050.15 15.11 -0.49%

Market Movers

Name
Last price
Change
% Change
Spartan Resources Ltd SPR 0.64 0.01 -1.66%
Imugene Ltd IMU 0.09 0.01 19.72%
Base Resources Ltd BSE 0.24 0.13 123.81%
Sayona Mining Ltd SYA 0.03 0.00 3.03%
South32 Ltd S32 3.37 0.18 5.64%
The Star Entertainment Group Ltd SGR 0.42 0.01 -1.19%
Telstra Group Ltd TLS 3.70 0.05 1.37%
Zip Co Ltd ZIP 1.18 0.09 7.80%
Droneshield Ltd DRO 0.94 0.18 -16.07%
Pilbara Minerals Ltd PLS 3.86 0.03 0.78%